The United States Influenza Vaccines Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Influenza Vaccines Market By Application
- Adults
- Children
- Elderly
- Pregnant Women
- Healthcare Workers
The United States influenza vaccines market is segmented by application into several key . Vaccination among adults remains a significant portion of the market, driven by public health campaigns and employer-sponsored programs aimed at reducing influenza-related morbidity and mortality in the working-age population. Children represent another crucial segment, with pediatric influenza vaccination programs supported by recommendations from healthcare providers and school immunization mandates. In addition, the elderly population is a major target for influenza vaccination due to their higher susceptibility to severe influenza complications.
Vaccination of pregnant women is also a growing area of focus, supported by guidelines from health authorities advocating influenza vaccination during pregnancy to protect both the mother and the developing fetus. Furthermore, healthcare workers form a vital subsegment, as they are often required to receive influenza vaccination to reduce transmission to vulnerable patient populations and ensure continuity of healthcare services during the influenza season.